Showing results (461-470 of 912) with videos related to

Sort By:
Pageof 92
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Successful treatment with mecobalamin in a pernicious anemia patient presenting with false-normal serum vitamin B12]Tsutomu Shishido, Yuki Hiroshima, Nozomu Uematsu, et al.
Acta Cytologica|May 28, 2025
New WHO Reporting System for Lung Cytopathology: Reproducibility Test of the Diagnosis and Usefulness of an Online Tutorial System for the New Cytological CategorizationYuko Minami, Akemi Takenaka, Kenzo Hiroshima, et al.
Journal of Arrhythmia|October 14, 2022
Clinical outcome for heart failure hospitalizations in patients with leadless pacemakerTomonori Katsuki, Michio Nagashima, Hiroyuki Kono, et al.
Anticancer Research|January 30, 2022
CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in MiceYuzo Minegishi, Yukihiko Hiroshima, Keiichi Yazawa, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
Serum endostatin correlates with progression and prognosis of non-small cell lung cancerMakoto Suzuki, Toshihiko Iizasa, Eitetu Ko, et al.
Cancer|February 6, 2003
Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinomaMasato Shingyoji, Yuichi Takiguchi, Reiko Watanabe, et al.
Thorax|September 27, 2002
Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscopeK Shibuya, H Hoshino, M Chiyo, et al.
American Journal of Cancer Research|February 14, 2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathwayBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Cancers|September 23, 2022
Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative ResectionItaru Hashimoto, Yayoi Kimura, Naohide Oue, et al.
Springerplus|July 21, 2015
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Pageof 92